Author Maass, Fabian

• 2019 | Journal Article
  ​ ​Cerebrospinal fluid biomarker for Parkinson's disease: An overview​
  Maass, F.; Schulz, I.; Lingor, P.; Mollenhauer, B. & Bähr, M. ​ (2019) 
  Molecular and Cellular Neuroscience, 97 pp. 60​-66​.​ DOI: https://doi.org/10.1016/j.mcn.2018.12.005 
  ​Details  DOI 

• 2019 | Journal Article | 
  ​ ​Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson’s Disease​
  Zella, M.; Metzdorf, J.; Ostendorf, F.; Maass, F.; Muhlack, S.; Gold, R. & Haghikia, A. et al.​ (2019) 
  Cells, 8(2) pp. 105​.​ DOI: https://doi.org/10.3390/cells8020105 
  ​Details  DOI 

• 2020 | Journal Article
  ​ ​Human cerebrospinal fluid data for use as spectral library, for biomarker research​
  Schilde, L. M.; Steinbach, S.; Serschnitzki, B.; Maass, F.; Bähr, M.; Lingor, P. & Marcus, K. et al.​ (2020) 
  Data in Brief, 32 pp. 106048​.​ DOI: https://doi.org/10.1016/j.dib.2020.106048 
  ​Details  DOI 

• 2021 | Journal Article
  ​ ​Validation of Plasma Neurofilament Light Chain as a Marker for α‐Synucleinopathies​
  Schmitz, M.; Canaslan, S.; Villar‐Piqué, A.; Gmitterová, K.; Varges, D.; Lingor, P. & Llorens, F. et al.​ (2021) 
  Movement Disorders, art. mds.28724​.​ DOI: https://doi.org/10.1002/mds.28724 
  ​Details  DOI 

• 2021 | Journal Article
  ​ ​MicroRNAs from extracellular vesicles as a signature for Parkinson's disease​
  Caldi Gomes, L.; Roser, A.; Jain, G.; Pena Centeno, T.; Maass, F.; Schilde, L. & May, C. et al.​ (2021) 
  Clinical and Translational Medicine, 11(4).​ DOI: https://doi.org/10.1002/ctm2.357 
  ​Details  DOI 

• 2021 | Journal Article | Research Paper | 
  ​ ​Detection of Cerebrospinal Fluid Neurofilament Light Chain as a Marker for Alpha-Synucleinopathies​
  Canaslan, S.; Schmitz, M.; Villar-Piqué, A.; Maass, F.; Gmitterová, K.; Varges, D. & Lingor, P. et al.​ (2021) 
  Frontiers in Aging Neuroscience, 13.​ DOI: https://doi.org/10.3389/fnagi.2021.717930 
  ​Details  DOI 

• 2022 | Journal Article
  ​ ​Validation of Plasma and CSF Neurofilament Light Chain as an Early Marker for Sporadic Creutzfeldt-Jakob Disease​
  Schmitz, M.; Canaslan, S.; Espinosa, J. C.; Fernández-Borges, N.; Villar-Piqué, A.; Llorens, F. & Varges, D. et al.​ (2022) 
  Molecular Neurobiology,.​ DOI: https://doi.org/10.1007/s12035-022-02891-7 
  ​Details  DOI 

• 2022 | Journal Article | Research Paper
  ​ ​Baseline Cerebrospinal Fluid alpha-Synuclein in Parkinson's Disease Is Associated with Disease Progression and Cognitive Decline​
  Emdina, A.; Hermann, P.; Varges, D.; Nuhn, S.; Goebel, S.; Bunck, T. & Maass, F. et al.​ (2022) 
  Diagnostics, 12(5) art. 1259​.​ DOI: https://doi.org/10.3390/diagnostics12031259 
  ​Details  DOI 

• 2022 | Journal Article
  ​ ​Multi‐omic landscaping of human midbrains identifies disease‐relevant molecular targets and pathways in advanced‐stage Parkinson's disease​
  Caldi Gomes, L.; Galhoz, A.; Jain, G.; Roser, A.; Maass, F.; Carboni, E. & Barski, E. et al.​ (2022) 
  Clinical and Translational Medicine, 12(1).​ DOI: https://doi.org/10.1002/ctm2.692 
  ​Details  DOI 

• 2022 | Journal Article | Research Paper | 
  ​ ​Baseline Cerebrospinal Fluid α-Synuclein in Parkinson’s Disease Is Associated with Disease Progression and Cognitive Decline​
  Emdina, A.; Hermann, P.; Varges, D.; Nuhn, S.; Goebel, S.; Bunck, T. & Maass, F. et al.​ (2022) 
  Diagnostics, 12(5) pp. 1259​.​ DOI: https://doi.org/10.3390/diagnostics12051259 
  ​Details  DOI 

• 2022 | Journal Article | Research Paper
  ​ ​The relevance of synuclein autoantibodies as a biomarker for Parkinson's disease​
  Garg, P.; Maass, F.; Sundaram, S. M.; Mollenhauer, B.; Mahajani, S.; van Riesen, C. & Kügler, S. et al.​ (2022) 
  Molecular and Cellular Neuroscience, 121 art. 103746​.​ DOI: https://doi.org/10.1016/j.mcn.2022.103746 
  ​Details  DOI  PMID  PMC 

• 2023 | Journal Article
  ​ ​Detection of Prion Protein Seeding Activity in Tear Fluids​
  Schmitz, M.; Silva Correia, S.; Hermann, P.; Maass, F.; Goebel, S.; Bunck, T. & Correia, A. et al.​ (2023) 
  New England Journal of Medicine, 388(19) pp. 1816​-1817​.​ DOI: https://doi.org/10.1056/NEJMc2214647 
  ​Details  DOI 

• 2023 | Journal Article | 
  ​ ​Brainstem atrophy in dementia with Lewy bodies compared with progressive supranuclear palsy and Parkinson’s disease on MRI​
  Müller, S. J.; Khadhraoui, E.; Hansen, N.; Jamous, A.; Langer, P.; Wiltfang, J. & Riedel, C. H. et al.​ (2023) 
  BMC Neurology, 23(1) art. 114​.​ DOI: https://doi.org/10.1186/s12883-023-03151-4 
  ​Details  DOI 

• 2023 | Journal Article | 
  ​ ​Spinocerebellar Ataxia Type 35 Caused by a New TGM6 Variant: Video Documentation of a German Family​
  Maass, F.; Jamous, A.; Biskup, S.; Eisenberg, H.; D'Hedouville, Z.; Bähr, M. & van Riesen, C.​ (2023) 
  Movement Disorders Clinical Practice, 10(6) art. mdc3.13717​.​ DOI: https://doi.org/10.1002/mdc3.13717 
  ​Details  DOI 

• 2024 | Journal Article
  ​ ​Metal dyshomeostasis in the substantia nigra of patients with Parkinson's disease or multiple sclerosis​
  Carmona, A.; Carboni, E.; Gomes, L. C.; Roudeau, S.; Maass, F.; Lenz, C. & Ortega, R. et al.​ (2024) 
  Journal of Neurochemistry, 168(2) pp. 128​-141​.​ DOI: https://doi.org/10.1111/jnc.16040 
  ​Details  DOI 

• 2024 | Journal Article
  ​ ​Glypican-4 serum levels are associated with cognitive dysfunction and vascular risk factors in Parkinson’s disease​
  Tatenhorst, L.; Maass, F.; Paul, H.; Dambeck, V.; Bähr, M.; Dono, R. & Lingor, P.​ (2024) 
  Scientific Reports, 14(1).​ DOI: https://doi.org/10.1038/s41598-024-54800-8 
  ​Details  DOI 

Researcher

Sort

Items per Page